Skip to main content

COVID-19

1 - 10 of 29 Results
Chemist nurse sitting in scientific lab examining virus evolution. Image from Envato

Non-covalent inhibitors of SARS-CoV-2 MPro are sought as new antiviral therapies because these compounds are fully reversible non-peptidic inhibitors, they do not interact covalently, and potentially irreversibly, with other proteins in a cell potentially reducing side effects